Abstract: Ovarian cancer, with high heterogeneity, is the second common cancer in the female reproductive system malignancy tumors. The molecular typing of ovarian cancer has provided a new basis for exploring its heterogeneity, prognosis evaluation and individualized treatment regimen. This paper reviews the advances in molecular typing of ovarian cancer and its clinical application.